Semiconductor heavyweights Advanced Micro Devices, Inc. (NASDAQ:AMD) and Intel Corporation (NASDAQ:INTC) have been in the headlines lately, with AMD capitalizing on initial reports of Intel's recent Spectre security flaw -- then admitting its own chips were also vulnerable. Speculators have responded by rushing to trade AMD options; this week, the stock takes the No. 9 spot on our list of equitie...Read More

While biotech mergers have dominated the headlines today, reports of a possible team-up in the agriculture industry have also raised eyebrows. Specifically, Archer Daniels Midland Company (NYSE:ADM) could be testing the M&A waters, after it was reported the company proposed a takeover of rival grain trader Bunge Ltd (NYSE:BG). Below, we will break down how ADM stock has reacted to the news.At las...Read More

Xerox Corp (NYSE:XRX) is trading up, after Carl Icahn demanded the $8 billion printing company put itself up for sale. The activist investor, along with fellow XRX stakeholder Darwin Deason, encouraged Xerox to explore strategic options, said they will elect four new board members, and requested the resignation of CEO Jeff Jacobson. This follows last week's letter, where the two -- who collectivel...Read More

The S&P 500 Index (SPX) and Nasdaq Composite (IXIC) both jumped to record highs today, despite uncertainty surrounding the government shutdown. While Senate Majority Leader Mitch McConnell has scheduled a vote this afternoon, the latest reports suggest there's no guarantee Democrats and Republicans will strike a deal. Investors are also digesting big healthcare M&A news and looking ahead to the la...Read More

Juno Therapeutics Inc (NASDAQ:JUNO) agreed to be bought out by Celgene Corporation (NASDAQ:CELG), confirming last week's reports in the Wall Street Journal. CELG already owns a 9.7% stake in JUNO, but will purchase the remainder of the company in an all-cash deal valued at roughly $9 billion, or $87 per JUNO share -- allowing it access to the Seattle-based firm's CAR-T cancer drug pipeline.At last...Read More

Array Biopharma Inc (NASDAQ:ARRY) is up 13.7% to trade at $14.93, and earlier touched a 16-year high of $15.66, after Leerink upgraded the cancer treatment specialist to "outperform" from "market perform," while issuing a price-target hike to $19 from $12. The upgrade comes after the biotech stock reported strong clinical results over the weekend from its BEACON cancer treatment trials, with Leeri...Read More

Cybersecurity stock Palo Alto Networks Inc (NYSE:PANW) touched an annual high last week after an upgrade from Evercore ISI, who said the company has "room to flourish." It's a different story today, however, with PANW stock sliding 3.1% to trade at $152.29 following bearish attention from Goldman Sachs. The firm downgraded the shares to "neutral" from "buy" and trimmed its price target to $168 fro...Read More

Despite a stellar year on the charts, tech titan Apple Inc (NASDAQ:AAPL) is trading 0.7% lower at $177.49 today, after the FAANG stock received its second downgrade in as many weeks. This time, the bearish note came from Atlantic Equities, which cut its AAPL rating to "neutral" from "overweight, " citing softening iPhone demand. The brokerage firm also reduced its current-quarter revenue estimate...Read More

U.S. stock futures are trading below fair value, as the government shutdown extends to a third day. The Senate failed to pass a short-term spending bill over the weekend, though Majority Leader Mitch McConnell has scheduled a vote for 12 p.m. ET today for a stopgap bill that would fund the federal government through Feb. 8. Among individual stocks, Netflix (NFLX) will likely be in focus ahead of t...Read More

"On Wednesday, the RSI moved above 80 for the first time since Feb. 21, 2017. Looking back at data for the SPDR S&P 500 ETF (SPY - 277.92)since 1993, this has happened only eight times. Although it is a limited sample size, when RSI reaches this level, the SPY has historically underperformed over one-week and one-month times. The other big takeaway is that the SPY has outperformed over three-month...Read More

Stocks finished a seesaw session higher, with the S&P and Nasdaq picking up record highs, with help from a rally in the chip sector. Traders ultimately brushed off fears of a possible government shutdown this weekend, as the Senate showed no signs of passing a budget agreement. Even the Dow ended the day in the black, shrugging off earnings disappointments from IBM Corp (IBM) and American Express...Read More

It's a mixed session on Wall Street today, as traders await updates on the budget showdown in D.C. Among individual stocks making notable moves are embattled blue chip General Electric Company (NYSE:GE), pharmaceutical firm Valeant Pharmaceuticals Intl Inc (NYSE:VRX), and e-commerce giant Amazon.com, Inc. (NASDAQ:AMZN). Here's a quick look at what's moving shares of GE, VRX, and AMZN.GE Stock Hit...Read More

U.S. stocks hit new highs again this week, with the Dow Jones Industrial Average (DJI) soaring past the 26,000 level, thanks to another round of well-received fourth-quarter earnings reports. The momentum stalled by week's end, however, when profit-taking and fears of a government shutdown took hold on Wall Street. As a result, the CBOE Volatility Index (VIX) notched its best weekly win since Dec...Read More

The shares of biotech Exelixis, Inc. (NASDAQ:EXEL) -- which makes Cabometyx -- have been in a channel of higher highs and lows since early 2016, gaining 55% over the past year. Since its most recent test of the $32-$32.50 range -- home to its Oct. 16 record high -- earlier this month, EXEL stock has given back about 13%, and was last seen 0.3% lower to trade at $27.80. However, the drug stock coul...Read More

The S&P 500 Index (SPX) has surged nearly 4.8% so far in January -- and there's still more than a week of trading left -- on pace for its best month since March 2016, and its 10th straight monthly gain. However, even as U.S. stocks assail record heights, the CBOE Volatility Index (VIX) -- or Wall Street's "fear gauge" -- is also on pace for a big month, currently up 4.3% in 2018. This rare occurre...Read More

On Thursday, Facebook Inc (NASDAQ:FB) snapped its six-session losing streak -- its longest since December 2016. This negative price action came after FB stock topped out at a record high of $188.90 on Jan. 8, and was exacerbated by a rare downgrade following news of changes to the company's News Feed. However, the equity is now stabilizing above a key trendline.Specifically, FB is currently tradin...Read More

Earnings season is officially in full swing, with next week featuring off some high-profile names of its own. Among those slated to report is streaming giant Netflix, Inc. (NASDAQ:NFLX), which is scheduled to unveil its fourth-quarter earnings after the stock market closes on Monday, Jan. 22. Ahead of the event, NFLX stock this morning received price-target hikes from Rosenblatt to $265 from $225,...Read More

The U.S. stock market is mixed, as the Senate shows no signs of passing a budget agreement to avoid a government shutdown. Though the CBOE Volatility (VIX) is lower, non-cyclical consumer goods stocks are seeing notable buying, and gold futures are on the rise -- hinting at strong demand for "safer" assets. One bright spot has been the retail sector, led by strong gains from blue chip Nike (NKE),...Read More

Jack Dorsey's portfolio is in focus today, after Square Inc (NYSE:SQ) and Twitter Inc (NYSE:TWTR) both received some bullish brokerage attention. Here's a quick look at the analyst notes issued for shares of SQ and TWTR, and how the stocks are reacting.Nomura Instinet Eyes Another 'Phenomenal' Year for SQNomura Instinet raised its price target on Square stock by $16 to $64 -- the highest on Wall S...Read More

Sirius XM Holdings Inc. (NASDAQ:SIRI) and Nvidia Corporation (NASDAQ:NVDA) stocks have both been winners in recent years, andare again gaining today following bullish brokerage attention. Below we'll take a closer look at shares of SIRI and NVDA after the analyst notes. Deutsche Bullish On SIRI StockShares of Sirius XM are trading up 1.8% at $5.57, after Deutsche Bank upgraded the stock to "buy"...Read More